News Sentiment

ZURA sentiment intelligence

Zura Bio Limited Class A Ordinary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 36 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 5.11 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

84/100 classification confidence.

Company focus 28

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-1.2% over one week, +38.1% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

What's Going on With Zura Bio Stock Wednesday? - Zura Bio (NASDAQ:ZURA)

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 84/100 classification
One-week reaction -1.2% Price digesting
Trend fit Trend inactive 38.1% over four weeks
Fair value 35.1% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 29
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 28
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 19
Market source 6
simplywall.st 3
TradingView 2
Business Wire 2
Benzinga 1
Sahm 1
www.marketscreener.com 1

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 8
Balance sheet 4
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 36
Stock Titan Direct company coverage

Zura Bio (NASDAQ: ZURA) furnishes updated corporate presentation for investors

Zura Bio Limited has released an updated corporate presentation dated July 1, 2026, for upcoming investor meetings and conferences. This presentation, furnished as Exhibit 99.1 to a Form 8-K filing, details the company's lead program, tibulizumab, a bispecific antibody targeting

Tone
Positive 62/100
Event
Market update
Published
01 Jul 2026 10:39
Source
Stock Titan
Stock Titan Direct company coverage

Zura Bio (ZURA) VP details share, RSU and option holdings

Zura Bio's VP and Principal Accounting Officer, Mathew Marlyn Teresa, reported his holdings as per a Form 3 filing. He holds 129,182 Class A ordinary shares, including 32,296 shares underlying restricted stock units that will vest in May 2027. Additionally, he possesses several e

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 04:11
Source
Stock Titan
Stock Titan Direct company coverage

Zura Bio (NASDAQ: ZURA) director receives grant of 51,000 share options

Zura Bio Ltd. director Jennifer Jarrett received a grant of 51,000 Class A Ordinary Share options with an exercise price of $3.62 per share, expiring on June 17, 2036. The options will vest in twelve equal monthly installments over one year, starting June 17, 2026, contingent on

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 04:11
Source
Stock Titan
Stock Titan Direct company coverage

Zura Bio (ZURA) director awarded 51,000 share options at $3.62

Zura Bio Ltd. director Parvinder Thiara was granted 51,000 share options for Class A Ordinary Shares at an exercise price of $3.62, expiring on June 17, 2036. The options will vest in twelve equal monthly installments starting June 17, 2026, contingent on Thiara's continued servi

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:11
Source
Stock Titan
Stock Titan Direct company coverage

Zura Bio (ZURA) director receives grant of 51,000 stock options

Zura Bio Ltd. director Steven J. Schoch was granted 51,000 stock options as compensation. These options allow him to buy Class A Ordinary Shares at an exercise price of $3.62 per share, expiring on June 17, 2036. The options will vest in twelve equal monthly installments over a o

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:11
Source
Stock Titan
Stock Titan Direct company coverage

Director at Zura Bio (NASDAQ: ZURA) granted 51,000 stock options

Zura Bio Ltd director Ajay Nirula was granted 51,000 share options at an exercise price of $3.62 per share, expiring on June 17, 2036. The options will vest in twelve equal monthly installments over one year starting June 17, 2026, contingent on his continued service. This transa

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:11
Source
Stock Titan
Stock Titan Direct company coverage

Zura Bio (ZURA) director receives 51,000 share options at $3.62 strike price

Zura Bio Ltd. director Mark Eisner was granted 51,000 share options for Class A Ordinary Shares with an exercise price of $3.62 per share, expiring on June 17, 2036. This compensation-related award vests in monthly installments over one year, subject to his continued service. Fol

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:11
Source
Stock Titan
Stock Titan Direct company coverage

Zura Bio (NASDAQ: ZURA) investors approve board slate, auditor and 2023 equity plan changes

Zura Bio Limited shareholders approved the re-election of all eight director nominees, ratified the appointment of WithumSmith+Brown, PC as their independent registered public accounting firm for the fiscal year ending December 31, 2026, and adopted changes to their 2023 Equity I

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 20:39
Source
Stock Titan
www.marketscreener.com Direct company coverage

65,018,058 Class A Ordinary Shares of Zura Bio Limited are subject to a Lock-Up Agreement Ending on 26-MAY-2026.

65,018,058 Class A Ordinary Shares of Zura Bio Limited are under a 91-day lock-up agreement, preventing executive officers and directors from selling or transferring them. This lock-up period began on February 24, 2026, and will end on May 26, 2026. The agreement is designed to m

Tone
Neutral 50/100
Event
Market update
Published
26 May 2026 08:37
Source
www.marketscreener.com
Stock Titan Direct company coverage

Zura Bio (NASDAQ: ZURA) discloses resignation of director Someit Sidhu

Zura Bio Limited (NASDAQ: ZURA) has announced the resignation of director Someit Sidhu from its board of directors, effective May 21, 2026. The company stated that Sidhu's resignation was not due to any disagreements regarding its operations, policies, or practices. This informat

Tone
Neutral 50/100
Event
Market update
Published
22 May 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Venrock entities report 9.99% ownership in ZURA (ZURA)

Venrock-affiliated entities have filed an amended Schedule 13G reporting a beneficial ownership of 9.99% in Zura Bio Ltd (ZURA) as of March 31, 2026. This ownership is capped at 9,816,384 Class A Ordinary Shares due to a "Beneficial Ownership Blocker" provision within Pre-Funded

Tone
Neutral 50/100
Event
Market update
Published
15 May 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Great Point Partners, Dr. Jay & Nordahl report 4.44% in ZURA (ZURA)

Great Point Partners, Dr. Jeffrey R. Jay, and Ms. Lillian Nordahl have jointly reported a beneficial ownership of 4,215,930 Class A Ordinary Shares in Zura Bio Limited (ZURA), representing 4.44% of the class. This disclosure was made via a Schedule 13G/A filing, indicating a pass

Tone
Neutral 50/100
Event
Market update
Published
15 May 2026 13:09
Source
Stock Titan
Business Wire Direct company coverage

Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Zura Bio Limited announced inducement grants under Nasdaq Listing Rule 5635(c)(4). The company granted an option to purchase up to 600,000 Class A Ordinary Shares to its new Chief Business Officer, Muzammil Mustufa, with an exercise price of $4.80 per share. This award was approv

Tone
Positive 60/100
Event
Market update
Published
15 May 2026 01:08
Source
Business Wire
Stock Titan Direct company coverage

Zura Bio's new CBO gets options on 600,000 shares at $4.80

Zura Bio Limited granted its new Chief Business Officer, Muzammil Mustufa, an inducement award consisting of an option to purchase up to 600,000 Class A Ordinary Shares. The option has an exercise price of $4.80 per share, equal to the closing price on May 13, 2026, and will vest

Tone
Positive 72/100
Event
Market update
Published
13 May 2026 04:39
Source
Stock Titan
Stock Titan Direct company coverage

[SCHEDULE 13G/A] Zura Bio Ltd Amended Passive Investment Disclosure

This SEC filing (SCHEDULE 13G/A) details an amended passive investment disclosure for Zura Bio Limited (ZURA) as of March 31, 2026. Suvretta Capital Management, LLC, Averill Master Fund, Ltd., and Aaron Cowen are identified as reporting persons, collectively holding 9.9% of Class

Tone
Neutral 50/100
Event
Market update
Published
12 May 2026 22:15
Source
Stock Titan
Stock Titan Direct company coverage

Zura Bio (NASDAQ: ZURA) boosts cash with $134.6M raise as R&D loss deepens

Zura Bio reported a wider net loss of $24.2 million for Q1 2026, compared to $17.4 million a year prior, as the company significantly increased its research and development spending. This expanded R&D is primarily focused on advancing Phase 2 trials for its lead antibody, tibuliz

Tone
Neutral 50/100
Event
Balance sheet
Published
08 May 2026 09:40
Source
Stock Titan
Stock Titan Direct company coverage

Zura Bio (Nasdaq: ZURA) widens Q1 loss, boosts cash to $225.6M

Zura Bio (Nasdaq: ZURA) reported a widened net loss of $24.2 million, or $0.22 per share, in Q1 2026, up from $17.4 million in Q1 2025, due to increased R&D and G&A expenses as it advances its immunology pipeline. The company significantly boosted its cash and cash equivalents to

Tone
Neutral 50/100
Event
Balance sheet
Published
07 May 2026 11:40
Source
Stock Titan
Stock Titan Direct company coverage

JPMorgan reports 4.47M Zura Bio holdings (NASDAQ: ZURA) — 4.7% stake

JPMorgan Chase has filed an amended Schedule 13G/A, reporting a beneficial ownership of 4,471,316 Class A Ordinary Shares in Zura Bio Ltd (NASDAQ: ZURA), which represents a 4.7% stake. The filing indicates a passive investment with JPMorgan having sole voting and dispositive powe

Tone
Neutral 50/100
Event
Deals and strategy
Published
06 May 2026 18:10
Source
Stock Titan
Stock Titan Direct company coverage

Eight new Zura Bio hires get options tied to 615,160 shares

Zura Bio Limited announced that it granted inducement awards consisting of options to purchase up to 615,160 Class A Ordinary Shares to eight newly hired employees on April 30, 2026. These awards, approved by the Compensation Committee, are outside the Company's 2023 Equity Incen

Tone
Positive 64/100
Event
Market update
Published
04 May 2026 20:10
Source
Stock Titan